Policy & Medicine - Legal, Regulatory, and Compliance Issues

The Senate Finance Committee Majority Staff recently issued a report entitled, “Physician Owned Distributorships: An Update on Key…

We have been talking about the opioid addiction in America for several months now, from Congressional hearings, to new…

The Campaign for Sustainable Rx Pricing (CSRxP) held a forum on "market-based policy solutions to curb rising drug prices" at the…

Recently, the Centers for Medicare & Medicaid Services (CMS) published the final Quality Measure Development Plan…

Recent legal cases have highlighted the important issue of whether or not attorney-client privilege attaches to internal…

The European Generics Medicines Association is undergoing a "rebranding" of sorts. They recently changed their name to…

MedTech Europe adopted a new Code of Ethical Business Practice late last year. This article explores the purpose of the…

We have previously written about the way the American Board of Internal Medicine (ABIM) is seeking physician input on…

Day Two of the Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and…

The Bipartisan Policy Center has plans to host three educational forums over the next several months, focused on the…